Crédit Agricole S.A. : The long term upward trend could suffer in the short term
Entry price | Target | Stop-loss | Potential |
---|
€12.77 |
€12.15 |
€13.11 |
+4.86% |
---|
The breach of the resistance zone around 13.11 EUR seems hard to achieve. The most probable scenario therefore seems to be one in which a short term correction takes place for shares in Crédit Agricole.
Strengths● The group's activity appears highly profitable thanks to its outperforming net margins.
● The group usually releases upbeat results with huge surprise rates.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● The company is one of the best yield companies with high dividend expectations.
● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● The tendency within the weekly time frame is positive above the technical support level at 11.13 EUR
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at EUR 13.11.
● The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
● According to forecast, a sluggish sales growth is expected for the next fiscal years.
● For the past seven days, analysts have been lowering their EPS expectations for the company.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.